Using generative AI, MIT scientists designed novel antibiotics to combat two drug-resistant bacteria. “We’re excited about the new possibilities that this project opens up,” says Professor James Collins. “Our work shows the power of AI from a drug design standpoint.”
Professor John Joannopoulos, photonics pioneer and Institute for Soldier Nanotechnologies director, dies at 78
Over 50 years at MIT, the condensed-matter physicist led the development of photonic crystals, translating discoveries into wide-ranging applications in energy, medicine, and defense.
MIT scientists show how they’re developing AI // CBS Mornings
Professor Daniela Rus, director of CSAIL, speaks about her work developing AI-powered robots. “AI and robots are tools,” says Rus. “They are tools created by the people, for the people. And like any other tools they’re not inherently good or bad; they are what we choose to do with them. And I believe we can choose to do extraordinary things.”
MIT spinout Strand Therapeutics is making cancerous tumors light up // Forbes
Strand Therapeutics, co-founded by Jake Becraft PhD ’19, has developed a programmable drug that could one day shrink tumors in cancer patients. “It shocked even us,” says Becraft. “You hope something happens, but you don’t expect to see a huge response because these patients have already proven to have cancers so resistant to treatment.”
In a recent episode of the Science Quickly podcast from Scientific American, host Rachel Feltman joins Matthew Evans, the MathWorks Professor of Physics, at the MIT LIGO lab to talk about the last 10 years of gravitational-wave research. Gravitational waves were discovered in 2015 by the LIGO team. Since then, innovations from the LIGO Laboratory have changed our understanding of the universe and made major shifts across physics. Now they’re preparing for the next generation of gravitational-wave detectors.
0 Komentar untuk "AI vs. antibiotic resistance + remembering John Joannopoulos + rejection therapy"